IGF1 and breast carcinoma: While the mechanism responsible for shuttling MIER1α out of the nucleus in breast cancer patients is not known, alternative splicing to include the NES [3] or treatment of breast carcinoma cells with insulin or insulin-like growth factor 1 (IGF1) [7] were both shown to produce a similar change in subcellular localization.